» Articles » PMID: 28386761

Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis

Overview
Publisher Current Science
Specialty Rheumatology
Date 2017 Apr 8
PMID 28386761
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Knee and hip osteoarthritis (OA) are major public health problems worldwide causing pain, disability and impaired quality of life. This narrative paper discusses platelet-rich plasma (PRP) as a treatment for hip and knee OA, with a focus on evidence from randomised controlled trials (RCTs).

Recent Findings: Since the first RCT of PRP in 2012, there has been 15 RCTs in knee OA and three in hip OA, mostly comparing PRP to another intra-articular injection therapy, hyaluronic acid. All studies are of low to moderate methodological quality and use variable PRP protocols. In general, results showed that PRP is a safe treatment with potential to provide symptomatic benefit for OA at least in the short term (up to 12 months). Younger patients with less severe disease may be more responsive. There are no RCTs investigating the effects of PRP on OA structural changes. No definitive conclusions can be made about the effects of PRP in OA given methodological concerns and considerable heterogeneity between studies. Further high-quality research is needed to establish the clinical and cost-effectiveness of PRP, the patients most likely to benefit and the optimal PRP protocol.

Citing Articles

Comparison of hyaluronic acid and platelet-rich plasma in knee osteoarthritis: a systematic review.

Xu H, Shi W, Liu H, Chai S, Xu J, Tu Q BMC Musculoskelet Disord. 2025; 26(1):236.

PMID: 40069655 PMC: 11895219. DOI: 10.1186/s12891-025-08474-6.


Intra-Articular Hyaluronic Acid for Knee Osteoarthritis: A Systematic Umbrella Review.

Glinkowski W, Tomaszewski W J Clin Med. 2025; 14(4).

PMID: 40004802 PMC: 11856182. DOI: 10.3390/jcm14041272.


Therapeutic potential of SOX family transcription factors in osteoarthritis.

Huang Y, Wang Z Ann Med. 2025; 57(1):2457520.

PMID: 39887675 PMC: 11789227. DOI: 10.1080/07853890.2025.2457520.


Bone Marrow Aspirate Concentrate Injections for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials.

Han J, Jung M, Chung K, Jung S, Choi C, Kim S Orthop J Sports Med. 2024; 12(12):23259671241296555.

PMID: 39640186 PMC: 11618931. DOI: 10.1177/23259671241296555.


Factors affecting the therapeutic effects of multiple intra-articular injections of platelet-rich-plasma for knee osteoarthritis.

Kamada K, Matsushita T, Yamashita T, Matsumoto T, Iwaguro H, Kuroda R Asia Pac J Sports Med Arthrosc Rehabil Technol. 2024; 38:43-48.

PMID: 39391554 PMC: 11464242. DOI: 10.1016/j.asmart.2024.09.006.


References
1.
Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P . Ultrasound-Guided Injection of Platelet-Rich Plasma and Hyaluronic Acid, Separately and in Combination, for Hip Osteoarthritis: A Randomized Controlled Study. Am J Sports Med. 2016; 44(3):664-71. DOI: 10.1177/0363546515620383. View

2.
Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D . The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013; 29(12):2037-48. DOI: 10.1016/j.arthro.2013.09.006. View

3.
Mishra A, Woodall Jr J, Vieira A . Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2008; 28(1):113-25. DOI: 10.1016/j.csm.2008.08.007. View

4.
Sibbitt Jr W, Kettwich L, Band P, Chavez-Chiang N, DeLea S, Haseler L . Does ultrasound guidance improve the outcomes of arthrocentesis and corticosteroid injection of the knee?. Scand J Rheumatol. 2011; 41(1):66-72. DOI: 10.3109/03009742.2011.599071. View

5.
Kwon D, Park G, Lee S . The effects of intra-articular platelet-rich plasma injection according to the severity of collagenase-induced knee osteoarthritis in a rabbit model. Ann Rehabil Med. 2012; 36(4):458-65. PMC: 3438411. DOI: 10.5535/arm.2012.36.4.458. View